OraPharma Corporate Headquarters
400 Somerset Corporate Boulevard Bridgewater, NJ 08807, United States
We are striving to develop innovative solutions—from diagnosis to treatment and prevention—in oral care to help dental healthcare professionals and patients tackle challenges of today and tomorrow.
For 25 years and counting, we have been growing as a company and expanding our curated portfolio in oral health.
OraPharma was founded as a specialty pharmaceutical company dedicated to oral healthcare. Our flagship product, ARESTIN, was approved by the FDA in 2001.
OraPharma operated as a subsidiary of Johnson & Johnson.
OraPharma was acquired by Valeant Pharmaceuticals International, Inc., now known as Bausch Health Companies Inc., a multinational specialty pharmaceutical company with a broad range of branded and generic pharmaceuticals, over-the-counter products, and medical devices.
We expanded our portfolio with the acquisition of NeutraSal, a prescription oral rinse.
We are continuing our mission to offer innovative products for guided bone regeneration and guided tissue generation through a partnership with Datum Dental Ltd.
We launched a new awareness effort to reintroduce XERESE.
We strive to develop innovative solutions for today and tomorrow.
For 25 years and counting, we have been growing as a company and expanding our curated portfolio in oral health.
OraPharma was founded as a specialty pharmaceutical company dedicated to oral healthcare. Our flagship product, ARESTIN, was approved by the FDA in 2001.
OraPharma operated as a subsidiary of Johnson & Johnson.
OraPharma was acquired by Valeant Pharmaceuticals International, Inc., now known as Bausch Health Companies Inc., a multinational specialty pharmaceutical company with a broad range of branded and generic pharmaceuticals, over-the-counter products, and medical devices.
We expanded our portfolio with the acquisition of NeutraSal, a prescription oral rinse.
We are continuing our mission to offer innovative products for guided bone regeneration and guided tissue generation through a partnership with Datum Dental Ltd.
We launched a new awareness effort to reintroduce XERESE.
We strive to develop innovative solutions for today and tomorrow.
We continue to make a difference in patients’ lives and in dental practices with our comprehensive suite of products to address a range of oral health concerns.
(minocycline HCl) Microspheres, 1 mg
(Supersaturated Calcium Phosphate Rinse)
(acyclovir and hydrocortisone) cream 5%/1%
We provide dental professionals with tools and resources to educate patients on oral healthcare.
Visit OraPharma professional educationWe also collaborate with leading academic institutions and professional associations to benefit dental hygiene students and professionals. Notably, our Student Access program provides education and experience to dental hygiene students at dental hygiene schools nationwide. Since 2007, over 250 dental hygiene schools participate in this program annually.
Visit Student Access program
We are engaged in a partnership with Datum Dental Ltd. for the OSSIX product portfolio.
OSSIX portfolio
We partner with over 35 dental service organizations nationwide to support dental practices by ensuring access to our oral health products and other offerings.
PARTNER WITH US
We continually seek to collaborate and partner with academic, professional, and corporate entities to expand our offerings to help patients.
contact us
Culture, community, inclusion, and respect shape who we are at OraPharma. We provide opportunities to support individual growth, career management, and leadership development. It is our goal to make everyone feel respected and equally appreciated so that we are all dedicated to the same cause.
400 Somerset Corporate Boulevard Bridgewater, NJ 08807, United States
1-866-273-7846 OraPharma@OraPharma.com